Toll Free: 1-888-928-9744
Published: Aug, 2018 | Pages:
104 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
This report studies the global Dermatological Drugs market status and forecast, categorizes the global Dermatological Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various skin, nails, hair diseases, pigmentation, acne, wrinkles, psoriasis, and others. Different techniques are used in dermatology such as topical & systemic medications, laser therapy, radio therapy, photodynamic therapy, vitiligo surgery, dermatological surgery, and others. The global Dermatological Drugs market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The major manufacturers covered in this report Bayer Johnson & Johnson Pfizer Novartis GlaxoSmithKline AstraZeneca Galderma Amgen AbbVie Merck Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America Europe China Japan India Southeast Asia Other regions (Central & South America, Middle East & Africa) We can also provide the customized separate regional or country-level reports, for the following regions: North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Rest of Asia-Pacific Europe Germany France UK Italy Spain Russia Rest of Europe Central & South America Brazil Argentina Rest of South America Middle East & Africa Saudi Arabia Turkey Rest of Middle East & Africa On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into By drug type Prescription-Based Drugs Over-the-Counter Drugs By route of administration Topical Administration Oral Administration Parenteral Administration By dermatological diseases Acne Dermatitis Psoriasis Skin Cancer Rosacea Alopecia Others By Application, the market can be split into Acne Skin Infections Psoriasis Dermatitis Drugs Other The study objectives of this report are: To analyze and study the global Dermatological Drugs capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025); Focuses on the key Dermatological Drugs manufacturers, to study the capacity, production, value, market share and development plans in future. Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis. To define, describe and forecast the market by type, application and region. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends and factors driving or inhibiting the market growth. To analyze the opportunities in the market for stakeholders by identifying the high growth segments. To strategically analyze each submarket with respect to individual growth trend and their contribution to the market. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Dermatological Drugs are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered. Key Stakeholders Dermatological Drugs Manufacturers Dermatological Drugs Distributors/Traders/Wholesalers Dermatological Drugs Subcomponent Manufacturers Industry Association Downstream Vendors Available Customizations With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report: Regional and country-level analysis of the Dermatological Drugs market, by end-use. Detailed analysis and profiles of additional market players.
Table of Contents Global Dermatological Drugs Market Professional Survey Report 2018 1 Industry Overview of Dermatological Drugs 1.1 Definition and Specifications of Dermatological Drugs 1.1.1 Definition of Dermatological Drugs 1.1.2 Specifications of Dermatological Drugs 1.2 Classification of Dermatological Drugs 1.2.1 Prescription-Based Drugs 1.2.2 Over-the-Counter Drugs 1.3 Applications of Dermatological Drugs 1.3.1 Acne 1.3.2 Skin Infections 1.3.3 Psoriasis 1.3.4 Dermatitis Drugs 1.3.5 Other 1.4 Market Segment by Regions 1.4.1 North America 1.4.2 Europe 1.4.3 China 1.4.4 Japan 1.4.5 Southeast Asia 1.4.6 India 2 Manufacturing Cost Structure Analysis of Dermatological Drugs 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Dermatological Drugs 2.3 Manufacturing Process Analysis of Dermatological Drugs 2.4 Industry Chain Structure of Dermatological Drugs 3 Technical Data and Manufacturing Plants Analysis of Dermatological Drugs 3.1 Capacity and Commercial Production Date of Global Dermatological Drugs Major Manufacturers in 2017 3.2 Manufacturing Plants Distribution of Global Dermatological Drugs Major Manufacturers in 2017 3.3 R&D Status and Technology Source of Global Dermatological Drugs Major Manufacturers in 2017 3.4 Raw Materials Sources Analysis of Global Dermatological Drugs Major Manufacturers in 2017 4 Global Dermatological Drugs Overall Market Overview 4.1 2013-2018E Overall Market Analysis 4.2 Capacity Analysis 4.2.1 2013-2018E Global Dermatological Drugs Capacity and Growth Rate Analysis 4.2.2 2017 Dermatological Drugs Capacity Analysis (Company Segment) 4.3 Sales Analysis 4.3.1 2013-2018E Global Dermatological Drugs Sales and Growth Rate Analysis 4.3.2 2017 Dermatological Drugs Sales Analysis (Company Segment) 4.4 Sales Price Analysis 4.4.1 2013-2018E Global Dermatological Drugs Sales Price 4.4.2 2017 Dermatological Drugs Sales Price Analysis (Company Segment) 5 Dermatological Drugs Regional Market Analysis 5.1 North America Dermatological Drugs Market Analysis 5.1.1 North America Dermatological Drugs Market Overview 5.1.2 North America 2013-2018E Dermatological Drugs Local Supply, Import, Export, Local Consumption Analysis 5.1.3 North America 2013-2018E Dermatological Drugs Sales Price Analysis 5.1.4 North America 2017 Dermatological Drugs Market Share Analysis 5.2 Europe Dermatological Drugs Market Analysis 5.2.1 Europe Dermatological Drugs Market Overview 5.2.2 Europe 2013-2018E Dermatological Drugs Local Supply, Import, Export, Local Consumption Analysis 5.2.3 Europe 2013-2018E Dermatological Drugs Sales Price Analysis 5.2.4 Europe 2017 Dermatological Drugs Market Share Analysis 5.3 China Dermatological Drugs Market Analysis 5.3.1 China Dermatological Drugs Market Overview 5.3.2 China 2013-2018E Dermatological Drugs Local Supply, Import, Export, Local Consumption Analysis 5.3.3 China 2013-2018E Dermatological Drugs Sales Price Analysis 5.3.4 China 2017 Dermatological Drugs Market Share Analysis 5.4 Japan Dermatological Drugs Market Analysis 5.4.1 Japan Dermatological Drugs Market Overview 5.4.2 Japan 2013-2018E Dermatological Drugs Local Supply, Import, Export, Local Consumption Analysis 5.4.3 Japan 2013-2018E Dermatological Drugs Sales Price Analysis 5.4.4 Japan 2017 Dermatological Drugs Market Share Analysis 5.5 Southeast Asia Dermatological Drugs Market Analysis 5.5.1 Southeast Asia Dermatological Drugs Market Overview 5.5.2 Southeast Asia 2013-2018E Dermatological Drugs Local Supply, Import, Export, Local Consumption Analysis 5.5.3 Southeast Asia 2013-2018E Dermatological Drugs Sales Price Analysis 5.5.4 Southeast Asia 2017 Dermatological Drugs Market Share Analysis 5.6 India Dermatological Drugs Market Analysis 5.6.1 India Dermatological Drugs Market Overview 5.6.2 India 2013-2018E Dermatological Drugs Local Supply, Import, Export, Local Consumption Analysis 5.6.3 India 2013-2018E Dermatological Drugs Sales Price Analysis 5.6.4 India 2017 Dermatological Drugs Market Share Analysis 6 Global 2013-2018E Dermatological Drugs Segment Market Analysis (by Type) 6.1 Global 2013-2018E Dermatological Drugs Sales by Type 6.2 Different Types of Dermatological Drugs Product Interview Price Analysis 6.3 Different Types of Dermatological Drugs Product Driving Factors Analysis 6.3.1 Prescription-Based Drugs Growth Driving Factor Analysis 6.3.2 Over-the-Counter Drugs Growth Driving Factor Analysis 7 Global 2013-2018E Dermatological Drugs Segment Market Analysis (by Application) 7.1 Global 2013-2018E Dermatological Drugs Consumption by Application 7.2 Different Application of Dermatological Drugs Product Interview Price Analysis 7.3 Different Application of Dermatological Drugs Product Driving Factors Analysis 7.3.1 Acne of Dermatological Drugs Growth Driving Factor Analysis 7.3.2 Skin Infections of Dermatological Drugs Growth Driving Factor Analysis 7.3.3 Psoriasis of Dermatological Drugs Growth Driving Factor Analysis 7.3.4 Dermatitis Drugs of Dermatological Drugs Growth Driving Factor Analysis 7.3.5 Other of Dermatological Drugs Growth Driving Factor Analysis 8 Major Manufacturers Analysis of Dermatological Drugs 8.1 Bayer 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.2.1 Product A 8.1.2.2 Product B 8.1.3 Bayer 2017 Dermatological Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 Bayer 2017 Dermatological Drugs Business Region Distribution Analysis 8.2 Johnson & Johnson 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.2.1 Product A 8.2.2.2 Product B 8.2.3 Johnson & Johnson 2017 Dermatological Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 Johnson & Johnson 2017 Dermatological Drugs Business Region Distribution Analysis 8.3 Pfizer 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.2.1 Product A 8.3.2.2 Product B 8.3.3 Pfizer 2017 Dermatological Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 Pfizer 2017 Dermatological Drugs Business Region Distribution Analysis 8.4 Novartis 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.2.1 Product A 8.4.2.2 Product B 8.4.3 Novartis 2017 Dermatological Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 Novartis 2017 Dermatological Drugs Business Region Distribution Analysis 8.5 GlaxoSmithKline 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.2.1 Product A 8.5.2.2 Product B 8.5.3 GlaxoSmithKline 2017 Dermatological Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 GlaxoSmithKline 2017 Dermatological Drugs Business Region Distribution Analysis 8.6 AstraZeneca 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.2.1 Product A 8.6.2.2 Product B 8.6.3 AstraZeneca 2017 Dermatological Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 AstraZeneca 2017 Dermatological Drugs Business Region Distribution Analysis 8.7 Galderma 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.2.1 Product A 8.7.2.2 Product B 8.7.3 Galderma 2017 Dermatological Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 Galderma 2017 Dermatological Drugs Business Region Distribution Analysis 8.8 Amgen 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.2.1 Product A 8.8.2.2 Product B 8.8.3 Amgen 2017 Dermatological Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 Amgen 2017 Dermatological Drugs Business Region Distribution Analysis 8.9 AbbVie 8.9.1 Company Profile 8.9.2 Product Picture and Specifications 8.9.2.1 Product A 8.9.2.2 Product B 8.9.3 AbbVie 2017 Dermatological Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.9.4 AbbVie 2017 Dermatological Drugs Business Region Distribution Analysis 8.10 Merck 8.10.1 Company Profile 8.10.2 Product Picture and Specifications 8.10.2.1 Product A 8.10.2.2 Product B 8.10.3 Merck 2017 Dermatological Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.10.4 Merck 2017 Dermatological Drugs Business Region Distribution Analysis 9 Development Trend of Analysis of Dermatological Drugs Market 9.1 Global Dermatological Drugs Market Trend Analysis 9.1.1 Global 2018-2025 Dermatological Drugs Market Size (Volume and Value) Forecast 9.1.2 Global 2018-2025 Dermatological Drugs Sales Price Forecast 9.2 Dermatological Drugs Regional Market Trend 9.2.1 North America 2018-2025 Dermatological Drugs Consumption Forecast 9.2.2 Europe 2018-2025 Dermatological Drugs Consumption Forecast 9.2.3 China 2018-2025 Dermatological Drugs Consumption Forecast 9.2.4 Japan 2018-2025 Dermatological Drugs Consumption Forecast 9.2.5 Southeast Asia 2018-2025 Dermatological Drugs Consumption Forecast 9.2.6 India 2018-2025 Dermatological Drugs Consumption Forecast 9.3 Dermatological Drugs Market Trend (Product Type) 9.4 Dermatological Drugs Market Trend (Application) 10 Dermatological Drugs Marketing Type Analysis 10.1 Dermatological Drugs Regional Marketing Type Analysis 10.2 Dermatological Drugs International Trade Type Analysis 10.3 Traders or Distributors with Contact Information of Dermatological Drugs by Region 10.4 Dermatological Drugs Supply Chain Analysis 11 Consumers Analysis of Dermatological Drugs 11.1 Consumer 1 Analysis 11.2 Consumer 2 Analysis 11.3 Consumer 3 Analysis 11.4 Consumer 4 Analysis 12 Conclusion of the Global Dermatological Drugs Market Professional Survey Report 2017 Methodology Analyst Introduction Data Source
List of Tables and Figures Figure Picture of Dermatological Drugs Table Product Specifications of Dermatological Drugs Table Classification of Dermatological Drugs Figure Global Production Market Share of Dermatological Drugs by Type in 2017 Figure Prescription-Based Drugs Picture Table Major Manufacturers of Prescription-Based Drugs Figure Over-the-Counter Drugs Picture Table Major Manufacturers of Over-the-Counter Drugs Table Applications of Dermatological Drugs Figure Global Consumption Volume Market Share of Dermatological Drugs by Application in 2017 Figure Acne Examples Table Major Consumers in Acne Figure Skin Infections Examples Table Major Consumers in Skin Infections Figure Psoriasis Examples Table Major Consumers in Psoriasis Figure Dermatitis Drugs Examples Table Major Consumers in Dermatitis Drugs Figure Other Examples Table Major Consumers in Other Figure Market Share of Dermatological Drugs by Regions Figure North America Dermatological Drugs Market Size (Million USD) (2013-2025) Figure Europe Dermatological Drugs Market Size (Million USD) (2013-2025) Figure China Dermatological Drugs Market Size (Million USD) (2013-2025) Figure Japan Dermatological Drugs Market Size (Million USD) (2013-2025) Figure Southeast Asia Dermatological Drugs Market Size (Million USD) (2013-2025) Figure India Dermatological Drugs Market Size (Million USD) (2013-2025) Table Dermatological Drugs Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Dermatological Drugs in 2017 Figure Manufacturing Process Analysis of Dermatological Drugs Figure Industry Chain Structure of Dermatological Drugs Table Capacity and Commercial Production Date of Global Dermatological Drugs Major Manufacturers in 2017 Table Manufacturing Plants Distribution of Global Dermatological Drugs Major Manufacturers in 2017 Table R&D Status and Technology Source of Global Dermatological Drugs Major Manufacturers in 2017 Table Raw Materials Sources Analysis of Global Dermatological Drugs Major Manufacturers in 2017 Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Dermatological Drugs 2013-2018E Figure Global 2013-2018E Dermatological Drugs Market Size (Volume) and Growth Rate Figure Global 2013-2018E Dermatological Drugs Market Size (Value) and Growth Rate Table 2013-2018E Global Dermatological Drugs Capacity and Growth Rate Table 2017 Global Dermatological Drugs Capacity (MT) List (Company Segment) Table 2013-2018E Global Dermatological Drugs Sales (MT) and Growth Rate Table 2017 Global Dermatological Drugs Sales (MT) List (Company Segment) Table 2013-2018E Global Dermatological Drugs Sales Price (USD/Kg) Table 2017 Global Dermatological Drugs Sales Price (USD/Kg) List (Company Segment) Figure North America Capacity Overview Table North America Supply, Import, Export and Consumption (MT) of Dermatological Drugs 2013-2018E Figure North America 2013-2018E Dermatological Drugs Sales Price (USD/Kg) Figure North America 2017 Dermatological Drugs Sales Market Share Figure Europe Capacity Overview Table Europe Supply, Import, Export and Consumption (MT) of Dermatological Drugs 2013-2018E Figure Europe 2013-2018E Dermatological Drugs Sales Price (USD/Kg) Figure Europe 2017 Dermatological Drugs Sales Market Share Figure China Capacity Overview Table China Supply, Import, Export and Consumption (MT) of Dermatological Drugs 2013-2018E Figure China 2013-2018E Dermatological Drugs Sales Price (USD/Kg) Figure China 2017 Dermatological Drugs Sales Market Share Figure Japan Capacity Overview Table Japan Supply, Import, Export and Consumption (MT) of Dermatological Drugs 2013-2018E Figure Japan 2013-2018E Dermatological Drugs Sales Price (USD/Kg) Figure Japan 2017 Dermatological Drugs Sales Market Share Figure Southeast Asia Capacity Overview Table Southeast Asia Supply, Import, Export and Consumption (MT) of Dermatological Drugs 2013-2018E Figure Southeast Asia 2013-2018E Dermatological Drugs Sales Price (USD/Kg) Figure Southeast Asia 2017 Dermatological Drugs Sales Market Share Figure India Capacity Overview Table India Supply, Import, Export and Consumption (MT) of Dermatological Drugs 2013-2018E Figure India 2013-2018E Dermatological Drugs Sales Price (USD/Kg) Figure India 2017 Dermatological Drugs Sales Market Share Table Global 2013-2018E Dermatological Drugs Sales (MT) by Type Table Different Types Dermatological Drugs Product Interview Price Table Global 2013-2018E Dermatological Drugs Sales (MT) by Application Table Different Application Dermatological Drugs Product Interview Price Table Bayer Information List Table Product Overview Table 2017 Bayer Dermatological Drugs Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg) Figure 2017 Bayer Dermatological Drugs Business Region Distribution Table Johnson & Johnson Information List Table Product Overview Table 2017 Johnson & Johnson Dermatological Drugs Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg) Figure 2017 Johnson & Johnson Dermatological Drugs Business Region Distribution Table Pfizer Information List Table Product Overview Table 2017 Pfizer Dermatological Drugs Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg) Figure 2017 Pfizer Dermatological Drugs Business Region Distribution Table Novartis Information List Table Product Overview Table 2017 Novartis Dermatological Drugs Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg) Figure 2017 Novartis Dermatological Drugs Business Region Distribution Table GlaxoSmithKline Information List Table Product Overview Table 2017 GlaxoSmithKline Dermatological Drugs Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg) Figure 2017 GlaxoSmithKline Dermatological Drugs Business Region Distribution Table AstraZeneca Information List Table Product Overview Table 2017 AstraZeneca Dermatological Drugs Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg) Figure 2017 AstraZeneca Dermatological Drugs Business Region Distribution Table Galderma Information List Table Product Overview Table 2017 Galderma Dermatological Drugs Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg) Figure 2017 Galderma Dermatological Drugs Business Region Distribution Table Amgen Information List Table Product Overview Table 2017 Amgen Dermatological Drugs Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg) Figure 2017 Amgen Dermatological Drugs Business Region Distribution Table AbbVie Information List Table Product Overview Table 2017 AbbVie Dermatological Drugs Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg) Figure 2017 AbbVie Dermatological Drugs Business Region Distribution Table Merck Information List Table Product Overview Table 2017 Merck Dermatological Drugs Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg) Figure 2017 Merck Dermatological Drugs Business Region Distribution Figure Global 2018-2025 Dermatological Drugs Market Size (MT) and Growth Rate Forecast Figure Global 2018-2025 Dermatological Drugs Market Size (Million USD) and Growth Rate Forecast Figure Global 2018-2025 Dermatological Drugs Sales Price (USD/Kg) Forecast Figure North America 2018-2025 Dermatological Drugs Consumption Volume (MT) and Growth Rate Forecast Figure China 2018-2025 Dermatological Drugs Consumption Volume (MT) and Growth Rate Forecast Figure Europe 2018-2025 Dermatological Drugs Consumption Volume (MT) and Growth Rate Forecast Figure Southeast Asia 2018-2025 Dermatological Drugs Consumption Volume (MT) and Growth Rate Forecast Figure Japan 2018-2025 Dermatological Drugs Consumption Volume (MT) and Growth Rate Forecast Figure India 2018-2025 Dermatological Drugs Consumption Volume (MT) and Growth Rate Forecast Table Global Sales Volume (MT) of Dermatological Drugs by Type 2018-2025 Table Global Consumption Volume (MT) of Dermatological Drugs by Application 2018-2025 Table Traders or Distributors with Contact Information of Dermatological Drugs by Region
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.